About Us
Biotech Consortium India Limited (BCIL) is a public limited company, promoted by the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India and set up by All India Financial Institutions including IDBI, ICICI, IFCI, UTI and IFCI Venture Capital Funds Limited.
BCIL was incorporated under the Companies Act 1956(Now Company Act, 2013) in 1990 with government in advisory role, development banks as major funding agency.
It is a nodal agency for providing business support services to facilitate accelerated commercialization of biotech products and processes.
The company was inaugurated in 1990 by the then Prime Minister of India, Hon’ble Shri Chandra Shekhar, in presence of the Finance Minister, Shri. Yashwant Sinha and Dr. Manju Sharma, Secretary, Department of Biotechnology.
Read MoreLaunch of the New Public Portal For "Conference, Travel, Exhibition and Popular Lectures (CTEP)
Launch of the New Public Portal For "Conference, Travel, Exhibition and Popular Lectures (CTEP) of Department of Biotechnology, (DBT), Ministry of Science and Technology, Government of India, being managed by Biotech Consortium India Limited (BCIL) by Dr. Renu Swarup, Secretary, DBT on 14th June, 2018.
WHAT'S NEW
Biotech Consortium India Limited (BCIL) is delighted to announce the signing of a Memorandum of Agreement (MoA) with the Madhya Pradesh Council of Science & Technology (MPCOST) on 1st August 2026 in Bhopal, marking the beginning of a strategic partnership to strengthen the biotechnology and innovation ecosystem in Madhya Pradesh. The MoA was executed in the esteemed presence of Dr. Shekhar Mande President, Indian National Science Academy (INSA), Chairman, BCIL, and Former Secretary, DSIR & Director General, CSIR by Dr.
Uttarakhand State Council for Science and Technology and Biotech Consortium India Limited executed a Memorandum of Agreement in the areas of innovation management and technology transfer. The signing ceremony happened in presence of Prof. Durgesh Pant Director General, UCOST, Dr. Purnima Sharma, Managing Director, BCIL and other senior members of UCOST.
National Institute of Pharmaceutical Education and Research, Hyderabad (NIPER-Hyderabad) and Biotech Consortium India Limited (BCIL) executed a Memorandum of Agreement (MoA) for assisting NIPER in the areas of innovation management, technology transfer, facilitating collaborations with industry, spin off creation etc today (14th July 2026). The MoA was executed by Prof. Shailendra Saraf, Director, NIPER-Hyderabad and Dr. Purnima Sharma, Managing Director, BCIL in presence of senior faculty members in a ceremony organized at NIPER-Hyderabad. Dr.